Zdrowie i gospodarka · 27/05/2026
FDA Withdraws Hearing Requests for Estrogen-Androgen Fixed-Combination Drug Products
The FDA has withdrawn all outstanding hearing requests for estrogen-androgen fixed-combination drug products, finding they are not effective for use under prescribed conditions, and prohibits interstate shipment of non-approved products.